Log In
Print
BCIQ
Print
Print this Print this
 

TachoSil

  Manage Alerts
Collapse Summary General Information
Company Takeda Pharmaceutical Co. Ltd.
DescriptionHuman fibrinogen and thrombin hemostatic surgical patch
Molecular Target
Mechanism of Action 
Therapeutic ModalityBiologic
Latest Stage of DevelopmentMarketed
Standard IndicationBleeding
Indication DetailsImprove hemostasis; Prevent mild to moderate bleeding from small blood vessels in cardiovascular surgery
Regulatory Designation

Partner

Baxter International Inc.


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today